Education
About Us
Working with TipRanks
Follow Us
Plandai Biotechnology (PLPL)
:PLPL
PLPL Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EST
<$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
Volume21.95M
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$155.00K
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)-244.85
Price to Sales (P/S)0.00
P/FCF Ratio0.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
PLPL FAQ
What was Plandai Biotechnology’s price range in the past 12 months?
Currently, no data Available
What is Plandai Biotechnology’s market cap?
Currently, no data Available
When is Plandai Biotechnology’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Plandai Biotechnology’s earnings last quarter?
Currently, no data Available
Is Plandai Biotechnology overvalued?
According to Wall Street analysts Plandai Biotechnology’s price is currently Overvalued.
Does Plandai Biotechnology pay dividends?
Plandai Biotechnology does not currently pay dividends.
What is Plandai Biotechnology’s EPS estimate?
Plandai Biotechnology’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Plandai Biotechnology have?
Currently, no data Available
What happened to Plandai Biotechnology’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Plandai Biotechnology?
Currently, no hedge funds are holding shares in PLPL
Company Description
Plandai Biotechnology
Plandaí Biotechnology, Inc. focuses on the production of proprietary botanical extracts for the nutriceutical and pharmaceutical industries. It is developing Phytofare Catechin Complex, a botanical extract derived from green tea harvested in the Senteeko Tea Estate in Mpumalanga, South Africa; and Phytofare citrus complex, a citrus extract, as well as extracts from tomato fruit, Artemisia, and cannabis. The company also produces and sells timber and agricultural products from its farm and tea estate holdings in South Africa. Plandaí Biotechnology, Inc. is based in London, the United Kingdom.
Santech Holdings
―
Silexion Therapeutics
―
Real Messenger
―
CERo Therapeutics Holdings
―
Profusa
―
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---